Hepatic Encephalopathy clinical trials at UCSF
1 research study open to eligible people
Hepatic encephalopathy is caused by liver disease affecting the brain. UCSF is investigating treatments that use immune-modulating drugs to address this condition. These studies include trials focused on children to see how these drugs can improve their brain health.
TReatment for ImmUne Mediated PathopHysiology
open to eligible people ages 1-18
TReatment for ImmUne Mediated PathopHysiology (TRIUMPH) is a multi-center, three arm, randomized, controlled trial of immunosuppressive therapy for children with acute liver failure. The study will determine if suppressing inflammatory responses with either corticosteroids or equine anti-thymocyte globulin therapy improves survival for children with this rare, life-threatening condition.
San Francisco, California and other locations
Last updated: